Schedule 13G ownership disclosure
Akebia Therapeutics Inc
Common Stock · CUSIP: 00972D105
Event date: 2025-12-31
- Filing-level shares
- 19,219,819
- Percent of class
- 7.2%
- BlackRock, Inc.
Shares: 19,219,819 · Class: 7.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000635
- Form type
- SCHEDULE 13G/A
- Filer
- Akebia Therapeutics, Inc.
- CIK
- CIK 1517022
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership